Skip to content
AwardedPOLGoods

Dostawa produktów leczniczych

Published
Published 4 May 2026
Deadline
Closed 8 June 2026

Overview

The University Clinical Center of the Warsaw Medical University procured pharmaceutical products, specifically Axicabtagene ciloleucel and Brexucabtagene autoleuce, under a medical program for delivery to the Central Clinical Hospital. The contract was awarded to Gilead Sciences Poland Sp. z o.o. on 19 June 2026 for a value of 400,204,800 PLN.

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Open
Published
4 May 2026
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
PLN 400,204,800
Award date
19 June 2026
Contract period
— → 14 June 2027
Winner
  • GILEAD SCIENCES POLAND SPÓŁKĄ Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    24 June 2026

  2. Contract Notice

    28 May 2026

  3. Contract Notice

    4 May 2026

Contracting authority

  • Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego

    Procuring entity

    Warszawa, POL

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Dostawa produktów leczniczych — won by GILEAD SCIENCES POLAND SPÓŁKĄ Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ — Skim